Skip to main content

1 Result(s)

within G Garcia-Pardillos Remove this filter

and

  1. No Access

    Article

    The proteasome inhibitor bortezomib acts differently in combination with p53 gene transfer or cytotoxic chemotherapy on NSCLC cells

    In this report, the effects of a combined treatment with the proteasome inhibitor bortezomib and either a recombinant adeno-associated virus type 2 (rAAV-2)-mediated p53 gene transfer or chemotherapeutic agent...

    J Neukirchen, A Meier, A Rohrbeck, G Garcia-Pardillos, U Steidl… in Cancer Gene Therapy (2007)